Hartford Investment Management Co. lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 3.9% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,849 shares of the company’s stock after selling 322 shares during the period. Hartford Investment Management Co.’s holdings in Henry Schein were worth $572,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Summit Securities Group LLC bought a new stake in shares of Henry Schein during the second quarter worth about $31,000. Beach Investment Counsel Inc. PA bought a new stake in Henry Schein during the 2nd quarter worth approximately $37,000. Blue Trust Inc. increased its position in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares during the period. Mather Group LLC. raised its stake in shares of Henry Schein by 16.8% during the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after acquiring an additional 216 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt raised its stake in shares of Henry Schein by 282.1% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.
Henry Schein Trading Down 1.2 %
NASDAQ:HSIC opened at $70.00 on Friday. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $8.87 billion, a price-to-earnings ratio of 25.93, a PEG ratio of 2.00 and a beta of 0.86. The firm has a fifty day simple moving average of $70.57 and a two-hundred day simple moving average of $69.80. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $82.63.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on HSIC shares. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a research note on Friday, September 20th. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Evercore ISI raised their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Finally, Robert W. Baird dropped their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $77.50.
View Our Latest Analysis on Henry Schein
Insiders Place Their Bets
In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.14% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- Canadian Penny Stocks: Can They Make You Rich?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Why Are Stock Sectors Important to Successful Investing?
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.